Related references
Note: Only part of the references are listed.T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients
Laura Ghezzi et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Fate-Mapping of GM-CSF Expression Identifies a Discrete Subset of Inflammation-Driving T Helper Cells Regulated by Cytokines IL-23 and IL-1β
Juliana Komuczki et al.
IMMUNITY (2019)
GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System-Infiltrating Cells, but Is Dispensable for Disease Induction
Patrick C. Duncker et al.
JOURNAL OF IMMUNOLOGY (2018)
T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention
Jamie van Langelaar et al.
BRAIN (2018)
Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity
Kamar-Sulu N. Atretkhany et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Multiple sclerosis
Massimo Filippi et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
IFN-γ promotes transendothelial migration of CD4+ T cells across the blood-brain barrier
Sandip Ashok Sonar et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis
Dan Hu et al.
NATURE COMMUNICATIONS (2017)
Th1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes
Gabriel Arellano et al.
FRONTIERS IN IMMUNOLOGY (2017)
TNFR1 inhibition with a Nanobody protects against EAE development in mice
Sophie Steeland et al.
SCIENTIFIC REPORTS (2017)
GM-CSF is not essential for experimental autoimmune encephalomyelitis but promotes brain-targeted disease
Emily R. Pierson et al.
JCI INSIGHT (2017)
Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study
Eva Havrdova et al.
JOURNAL OF NEUROLOGY (2016)
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination
Pernille M. Madsen et al.
JOURNAL OF NEUROSCIENCE (2016)
IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23
Heather M. Grifka-Walk et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Integration of Th17-and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation
Natalia B. Pikor et al.
IMMUNITY (2015)
The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity
Andrew L. Croxford et al.
IMMUNITY (2015)
Silencing IFN-γ Binding/Signaling in Astrocytes versus Microglia Leads to Opposite Effects on Central Nervous System Autoimmunity
Xiaoli Ding et al.
JOURNAL OF IMMUNOLOGY (2015)
Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy
Javad Rasouli et al.
JOURNAL OF IMMUNOLOGY (2015)
Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Kevin S. Carbajal et al.
JOURNAL OF IMMUNOLOGY (2015)
TNF AND ITS RECEPTORS IN THE CNS: THE ESSENTIAL, THE DESIRABLE AND THE DELETERIOUS EFFECTS
L. Probert
NEUROSCIENCE (2015)
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation
Rebecca A. Sosa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis
Yonghao Cao et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis
Nichole M. Miller et al.
FRONTIERS IN NEUROSCIENCE (2015)
Involvement of CD8+ T Cells in Multiple Sclerosis
Marion Salou et al.
FRONTIERS IN IMMUNOLOGY (2015)
Opposing roles of interferon-gamma on cells of the central nervous system in autoimmune neuroinflammation
Payton A. Ottum et al.
FRONTIERS IN IMMUNOLOGY (2015)
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis
Cris S. Constantinescu et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation
Wanqiang Sheng et al.
CELL RESEARCH (2014)
Site-Specific Chemokine Expression Regulates Central Nervous System Inflammation and Determines Clinical Phenotype in Autoimmune Encephalomyelitis
Joshua S. Stoolman et al.
JOURNAL OF IMMUNOLOGY (2014)
Cytokine-Regulated Neutrophil Recruitment Is Required for Brain but Not Spinal Cord Inflammation during Experimental Autoimmune Encephalomyelitis
Sarah B. Simmons et al.
JOURNAL OF IMMUNOLOGY (2014)
Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS
Amanda K. Huber et al.
NEUROLOGY (2014)
Multiple sclerosis in the context of TNF blockade and inflammatory bowel disease
N. C. Hare et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2014)
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells
Rebecca Noster et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study
Evripidis Kaltsonoudis et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells
Felix J. Hartmann et al.
NATURE COMMUNICATIONS (2014)
The Interdependent, Overlapping, and Differential Roles of Type I and II IFNs in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
Rodrigo Naves et al.
JOURNAL OF IMMUNOLOGY (2013)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley H. Beecham et al.
NATURE GENETICS (2013)
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Adam P. Gregory et al.
NATURE (2012)
Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination
Roberta Brambilla et al.
BRAIN (2011)
IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathway
Mark A. Kroenke et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Th17 Cells Induce Ectopic Lymphoid Follicles in Central Nervous System Tissue Inflammation
Anneli Peters et al.
IMMUNITY (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Laura Codarri et al.
NATURE IMMUNOLOGY (2011)
The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF
Mohamed El-Behi et al.
NATURE IMMUNOLOGY (2011)
Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease
Margarita Dominguez-Villar et al.
NATURE MEDICINE (2011)
EAE mediated by a non-IFN-γ/non-IL-17 pathway
Mark A. Kroenke et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Jula Huppert et al.
FASEB JOURNAL (2010)
Astrocyte-Restricted Ablation of Interleukin-17-Induced Act1-Mediated Signaling Ameliorates Autoimmune Encephalomyelitis
Zizhen Kang et al.
IMMUNITY (2010)
GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization
Irah L. King et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Preferential Recruitment of Interferon-γ-Expressing TH17 Cells in Multiple Sclerosis
Hania Kebir et al.
ANNALS OF NEUROLOGY (2009)
Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease
Irah L. King et al.
BLOOD (2009)
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
Verena Brucklacher-Waldert et al.
BRAIN (2009)
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
Philip L. De Jager et al.
NATURE GENETICS (2009)
Autoimmune T cell responses in the central nervous system
Joan Goverman
NATURE REVIEWS IMMUNOLOGY (2009)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2008)
T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis
Chris J. Hedegaard et al.
IMMUNOLOGY (2008)
GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival
Ivo Sonderegger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
Mark A. Kroenke et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Regional CNS responses to IFN-γ determine lesion localization patterns during EAE pathogenesis
Jason R. Lees et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells:: Applicability to tumor-infiltrating T regulatory cells
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
Benjamin M. Segal et al.
LANCET NEUROLOGY (2008)
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells
Ingunn M. Stromnes et al.
NATURE MEDICINE (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology
Mandy J. McGeachy et al.
NATURE IMMUNOLOGY (2007)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis
Eugene D. Ponomarev et al.
JOURNAL OF IMMUNOLOGY (2007)
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Yutaka Komiyama et al.
JOURNAL OF IMMUNOLOGY (2006)
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
Y Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord
MA Gimenez et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
H Park et al.
NATURE IMMUNOLOGY (2005)
Apoptosis of oligodendrocytes via fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis
N Hövelmeyer et al.
JOURNAL OF IMMUNOLOGY (2005)
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis
HH Hofstetter et al.
CELLULAR IMMUNOLOGY (2005)
Demyelination-like syndrome in Crohn's disease after infliximab therapy
HJ Freeman et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
IFN-γ determines distinct clinical outcomes in autoimmune encephalomyelitis
AK Wensky et al.
JOURNAL OF IMMUNOLOGY (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients
JF Colombel et al.
GASTROENTEROLOGY (2004)
T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis
S Abromson-Leeman et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation
MAT Gimenez et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease
CW Thomas et al.
INFLAMMATORY BOWEL DISEASES (2004)
Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression
IR Moldovan et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity
MP Mycko et al.
BRAIN (2003)
A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis
N Arbour et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
DJ Cua et al.
NATURE (2003)
IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination
B Gran et al.
JOURNAL OF IMMUNOLOGY (2002)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
C Lock et al.
NATURE MEDICINE (2002)
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
HA Arnett et al.
NATURE NEUROSCIENCE (2001)
Granulocyte macrophage colony-stimulating factor: A new putative therapeutic target in multiple sclerosis
JL McQualter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: Implications for pathogenesis and therapy of autoimmune demyelination
G Kassiotis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
B Oppmann et al.
IMMUNITY (2000)
Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG35-55-induced experimental autoimmune encephalomyelitis
GC Suvannavejh et al.
CELLULAR IMMUNOLOGY (2000)
Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production
CM Pelfrey et al.
JOURNAL OF IMMUNOLOGY (2000)
Increased numbers of mononuclear cells from blood and CSF expressing interferon-gamma mRNA in multiple sclerosis are from both the CD4+and the CD8+subsets
E Wallstrom et al.
EUROPEAN JOURNAL OF NEUROLOGY (2000)
IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines
EH Tran et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
